In this report we have determined the phosphorylation pattern of human as1-casein by a combi-nation of matrix-assisted laser desorption mass spectrometry and amino acid sequence analysis
Trang 1The phosphorylation pattern of human as1-casein is markedly different from the ruminant species
Esben S Sørensen, Lise Møller, Maria Vinther, Torben E Petersen and Lone K Rasmussen*
Protein Chemistry Laboratory, Department of Molecular Biology, University of Aarhus, Denmark
Caseins are highly phosphorylated milk proteins assembled
in large colloidal structures termed micelles In the milk of
ruminants, as1-casein has been shown to be extensively
phosphorylated In this report we have determined the
phosphorylation pattern of human as1-casein by a
combi-nation of matrix-assisted laser desorption mass spectrometry
and amino acid sequence analysis Three phosphorylation
variants were identified A nonphosphorylated form, a
variant phosphorylated at Ser18 and a variant
phosphory-lated at Ser18 and Ser26 Both phosphorylation sites are located in the amino acid recognition sequence of the mammary gland casein kinase Notably, no phosphoryla-tions were observed in the conserved region covering resi-dues Ser70–Glu78, which is extensively phosphorylated in the ruminant as1-caseins
Keywords: as1-casein; human milk; mammary gland casein kinase; phosphorylation
Caseins are the predominant milk proteins of most
mammalian species [1] In ruminants, about 75% of the
milk protein content is constituted of caseins The
corresponding figure for human milk is only about 40%
[2] In the milk of ruminants, caseins interact with calcium
phosphate forming large stable colloidal particles termed
micelles These micellar complexes make it possible to
maintain a supersaturated calcium phosphate
concentra-tion in milk, providing the newborn with sufficient
calcium phosphate for the mineralization of the rapidly
growing calcified tissues In this context, the
phosphory-lation of the individual caseins plays a significant role in
the interaction with calcium phosphate and thereby the
organization of the micelles The ruminant caseins, which
are the most intensely studied, comprise as1-, as2-, b- and
j-casein Their phosphorylation pattern has been the basis of
many studies and the general feature is that they are highly
phosphorylated proteins, phosphorylated by the mammary
gland casein kinase [3–7] The primary requirement for
phosphorylation by this kinase is a glutamate, a
phospho-serine or an aspartate two residues to the C-terminal side of
the phosphoacceptor site (S-x-E/Sp/D) [8,9]
Compared with ruminants, human milk contains a very
low concentration of calcium phosphate and the function
of casein in delivering calcium to the neonate is therefore
muted in this species In human milk, the predominant
caseins are j- and b-casein, which differ from its ruminant
counterpart by a lower degree of phosphorylation [10] For many years it was generally accepted that as1-casein was absent or present in only very small amounts in human milk [2] In the mid-1990s, two groups isolated and sequenced a minor 27-kDa casein component that was identified as being the human counterpart of as1-casein [11,12] In addition, it was shown that this as1-casein component forms disulfide-bonded heteromultimers with j-casein in human milk [12] The molecular cloning and sequencing of mRNA transcripts revealed the presence of three forms of as1-casein in human milk [13,14] In the present study, we report the phosphorylation pattern of human as1-casein
Materials and methods Materials
Trypsin (EC 3.4.21.4) was obtained from Worthington Biochemical Corporation (Freehold, NJ, USA) Vydac C4 and C18 reverse-phase resins were from The Separations Group (Hesperia, CA, USA) and the RP C2/C18column was from Amersham Biosciences AB (Uppsala, Sweden) Reagents used for sequencing were from Applied Biosys-tems (Foster City, CA, USA) All other reagents were of analytical reagent grade
Purification of human as1-casein Human as1-casein was purified from human milk as described [12] During this procedure, the protein was reduced and alkylated to dissociate the disulfide-linked complex consisting of as1- and j-casein To remove small residual amounts of j-casein, the protein was subjected to reverse-phase chromatography on a Vydac C4reverse-phase column The purity of the resulting as1-casein was verified
by SDS/PAGE and N-terminal amino acid sequence analysis
Correspondence to E S Sørensen, Protein Chemistry Laboratory,
Department of Molecular Biology, University of Aarhus, Science
Park, Gustav Wieds Vej 10, DK-8000 Aarhus, Denmark.
Fax: + 45 8 6136597, Tel.: + 45 8 9425092,
E-mail: ess@imsb.au.dk
Enzyme: Trypsin (EC 3.4.21.4)
*Present address: Symphogen A/S, DK-2800 Denmark.
(Received 5 May 2003, revised 14 July 2003,
accepted 16 July 2003)
Trang 2Generation, separation and characterization of peptides
Approximately 300 lg of reduced and alkylated human
as1-casein was digested with trypsin using a ratio of enzyme
to substrate of 1 : 100 (w/w) in 0.1M ammonium
bicar-bonate, pH 8.1, at 37C for 6 h Separation of the peptides
was carried out by reverse-phase HPLC on a Vydac C18
column and detected in the effluent by measuring the
absorbency at 226 nm (as described in the legend to Fig 1)
Fraction 35 (Fig 1) was rechromatographed by
reverse-phase HPLC on a SMART-system equipped with a
2.1· 100 mm C2/C18 RPC column using a gradient of
acetonitrile in 0.05% heptafluorobutyric acid at 25C
Peptides were characterized by mass spectrometric- and
amino acid sequence analysis Mass spectrometric analyses
of the peptides were performed using a MALDI-TOF mass
spectrometer (Voyager DE PRO, Applied Biosystems Inc.)
Theoretical peptide masses were calculated using the
GPMAW program (Lighthouse Data, Odense, Denmark)
Amino acid sequence analysis was performed on an
automated amino acid sequencer (ABI 477A/120A; Applied
Biosystems Inc.) To locate phosphoserines in the sequence,
phosphopeptides were treated with ethanethiol to convert
phosphoserine into S-ethylcysteine [15] which can be
identified by amino acid sequence analysis as
PTH-S-ethylcysteine after its release in the corresponding cycle
PTH-S-ethylcysteine eluted just before the diphenylthiourea
peak in the system used [16]
Results and discussion
Human as1-casein was purified in a reduced and
carboxy-methylated state as described [12] The protein was digested
with trypsin and the resulting peptides were separated
by reverse-phase chromatography (Fig 1) Fractions were
collected and the peptides were characterized by mass
spectrometric- and sequence analysis The combined results
are shown in Table 1 The amino acid sequence of human
as1-casein is shown in Fig 2 Peptides identified by mass spectrometric analysis and/or sequence analysis are under-lined As seen in the Fig 2, peptides covering the entire
Fig 1 Reversed-phase separation of a trypsin digest of human a s1 -casein Human a s1 -casein was digested with trypsin as described in Materials and methods Peptides were eluted with a gradient of 80% acetonitrile in 0.1% trifluoroacetic acid (dotted line) on a Vydac
C 18 (10 lm) column (4 · 250 mm) The col-umn was operated at 40 EC and the flow rate was 0.85 mLÆmin)1 Peptides were detected in the effluent by recording the absorbance at
226 nm (solid line), collected manually and characterized as described in the text.
Table 1 Characterization of peptides from the tryptic digest of human
a s1 -casein Peak numbers designations correspond to those of Fig 1 The amino acid sequence was identified by sequence analysis and/or MALDI-TOF MS Calculated MH+, calculated protonated mono-isotopic masses; observed MH + , molecular monoisotopic protonated mass determined by MALDI-TOF MS.
Peak number Sequence Calculated MH+ Observed MH+
19 45–53 1105.55 1105.5
25 54–67 1605.71 1605.77
26 28–36 1143.46 1143.38
35–1 a 12–27+2P 1942.82 1942.78 35–2a 68–83 1718.75 1718.75
37 12–27+1P 1862.86 1862.78
38 12–27 1782.89 1782.86
41 12–36+2P 3067.34 3067.26
43 12–36+1P 2987.34 2987.26
44 91–109 2267.16 2267.15
49 164–171 904.44 904.38
53 142–163 2580.21 2580.44
54 111–132 2591.24 2591.18
54 133–141 1170.57 1170.5
62 133–163 3731.75 3731.12
65 111–163 6303.97 6303.61
a
Peaks from rechromatography of fraction 35 from Fig 1.
Trang 3sequence of human as1-casein have been identified and
characterized in this study
Glycosylation
Three asparagine residues in human as1-casein (Asn14,
Asn54, Asn154) are located in the putative glycosylation
sequence Asn-X-Ser/Thr In the case of Asn14 and Asn154,
a neighbouring proline residue in position X corrupts the
glycosylation sequence and renders it unfit for glycosylation
Regarding Asn54, this study did not show any evidence for
glycosylation of this residue in human as1-casein Mass
spectrometric analysis of peak 25 (Fig 1) containing the
peptide Asn54–Lys67 showed a mass of 1605.77 Da which
corresponds to the calculated protonated monoisotopic
mass (1605.71 Da) of the unmodified peptide sequence,
thereby showing that Asn54 was not glycosylated in human
as1-casein
Likewise in this study, we observed no O-glycosylations
in human as1-casein
Phosphorylation
Human as1-casein contains 16 serines and four threonines,
where nine of the serines and one threonine are located
in the recognition sequence of the mammary gland casein
kinase [8,9] The recognition sequence (Ser/Thr-X-Glu/
Ser(P)/Asp), comprises an acidic residue, glutamic acid,
aspartic acid or a phosphorylated residue, as the second
amino acid to the C-terminal side of the serine or threonine
to be targeted Especially interesting, human as1-casein
contains a serine rich region, SSISSSSEE(70–78), where five
of the serines are located in the recognition sequence of
the mammary gland casein kinase This region is highly
conserved among all species with known as1-casein
sequences (for alignment see [13]), and in all analyzed
species a high degree of phosphorylation has been observed
in this region [3–5]
Our laboratory has much experience of employing MALDI-TOF mass spectrometric analysis for identification and localization of phosphorylation sites in proteins [16–18] MALDI-TOF mass spectrometric analysis of a phospho-peptide results in a spectrum with an easily identifiable fragmentation pattern which is characteristic for phospho-rylated serines These spectra contain a series of peaks separated by approximately 98 Da, which represents the fragmentation of a phosphoserine to dehydroalanine
In this work, we have analyzed all fractions from the reverse-phase HPLC separation of the tryptic digest of human as1-casein (Fig 1) by MALDI-TOF mass spectro-metric and N-terminal sequence analysis We identified four fractions with the characteristic fragmentation pattern of peaks at 35, 37, 41 and 43 A representative MALDI-TOF spectrum of peak 41 showing the characteristic fragmenta-tion of a phosphopeptide is shown in Fig 3 Peak 35 was found to contain two peptides which potentially could be phosphorylated, thus the fraction was rechromatographed
by reversed-phase HPLC on a SMART HPLC system to separate the two components, 35–1 and 35–2 Peak 35–2 gave a mass spectrum with only one mass at 1718.75 Da which is identical with the calculated protonated mass for the tryptic peptide covering residues 68–83, thereby showing that this peptide is not phosphorylated in human as1-casein This observation was confirmed by Edman sequencing of the peptide, which showed normal yields of PTH-serine in all relevant cycles Mass analysis of peak 35–1 showed a mass of 1942.78 Da, as well as two populations of ions at approximately )98 Da and )196 Da This triplet of ions, each separated by approximately 98 Da, indicates that peak 35–1 contains a phosphopeptide with two phosphoserines Furthermore, the observed mass at 1942.78 Da correlates with the calculated protonated mass (1942.82 Da) for the tryptic peptide covering residues 12–27 and containing two phosphorylations (159.93 Da) Mass analysis of peak 37 showed a mass of 1862.78 Da, and a single fragmentation ion at)98 Da was observed, indicating the presence of a single phosphorylation in the peptide Furthermore, the
Fig 2 Localization of phosphorylations in human a s1 -casein The
amino acid sequence was deduced from the cDNA sequence [11] Solid
lines indicate isolated and characterized peptides (Table 1) P denotes
identified phosphorylation Peptides are numbered according to the
reversed-phase elution profile in Fig 1.
Fig 3 MALDI-TOF MS of peak 41 from Fig 1 The protonated mass at m/z 3067.26 corresponds to the peptide 12–36 including to phosphorylations The characteristic fragmentation pattern confirms the presence of two phosphorylations in the peptide.
Trang 4mass 1862.78 Da correlates with the calculated protonated
mass of residues 12–27 containing a single phosphorylation
(1862.86 Da) Finally, mass analysis of peak 38 showed a
mass which correlates with the mass of the peptide covering
residues 12–27 without any modifications In conclusion, we
have observed the peptide 12–27 in three different forms,
with zero, and one and two phosphate groups attached
Peaks 41 and 43 represent peptide 12–36 with two and one
phosphorylated groups, respectively These peptides,
result-ing from incomplete cleavage at Arg27, do not contain any
additional serines or threonines compared with peaks 35
and 37, and thus they were not characterized further
The peptide, LQNPSESSEPIPLESR(12–27) (peak
35–1), contains three serines located in the recognition
sequence of the mammary gland casein kinase (Ser16, Ser18
and Ser26) To determine which of the serines are in fact
phosphorylated, we subjected the two peptides to an
ethanethiol treatment followed by Edman sequencing as
outlined in Materials and methods The ethanethiol
treat-ment converts the labile phosphoserine residues into
S-ethylcysteine, which is more stable and able to withstand
the relatively harsh Edman chemistry during automated
sequencing [15] Furthermore, PTH-S-ethylcysteine elutes in
an open window just before the diphenylthiourea peak in
the on-line HPLC system used in these studies Sequence
analysis of peptide 35–1 succeeding the ethanethiol
treat-ment revealed PTH-S-ethylcysteine in cycles 7 and 15,
corresponding to Ser18 and Ser26 in human as1-casein
Likewise, sequence analysis of peptide 37, after the
ethanethiol treatment gave PTH-S-ethylcysteine in sequence
cycle 7, corresponding to Ser18 in human as1-casein The
yields of PTH-serine in cycles corresponding to Ser16 and
Ser19 were as expected, indicating that these residues were
not phosphorylated
As a control experiment (data not shown) human and
bovine b-casein were purified, tryptic digests were generated
and these were separated by reversed-phase HPLC using the
system and column described in Materials and methods In
MALDI-TOF MS analyses of the human b-casein digest,
two peptides with protonated masses of 2407.85 and
2327.80 were identified These masses correspond to the
expected masses of the peptide 1–18 of human b-casein with
four phosphorylations (2408.00) and three
phosphoryla-tions (2328.00), respectively Likewise in the digest of bovine
b-casein, a peptide with a protonated mass of 3122.27 was
observed, corresponding to the peptide 1–25 of bovine
b-casein with four phosphorylations (3122.40 Da) These
results indicate that the protocol used for identification of
phosphorylation sites is capable of handling highly
phos-phorylated peptides Furthermore, the methods used in the
present study have previously been used for identification
of phosphorylation sites in several milk proteins in our
laboratory, most prominently the 28 phosphorylation sites
in bovine milk osteopontin [16] Therefore it is not likely
that the lack of identification of a highly phosphorylated
peptide in as1-casein is due to limitations of the techniques
used
Finally, MALDI-TOF MS analysis of native human
as1-casein showed ions corresponding to a mass of
approxi-mately 20 232 Da, which correlates well with the calculated
mass of human as1-casein including two phosphate groups
(20246 Da) (Fig 4)
In conclusion, these studies show that human as1-casein exists in three phosphorylation variants A nonphosphory-lated form, a variant containing a single phosphorylation
at Ser18 and a variant phosphorylated at Ser18 and Ser26
It is difficult to determine the quantitative relation between the three phosphorylation variants, but judged by the reversed-phase HPLC trace in Fig 1, the variant containing a single phosphorylation at Ser18 is the major variant ( 50%), followed by the nonphosphorylated form ( 30%) and the doubly phosphorylated variant ( 20%) The degree of identity between human and other known
as1-casein sequences is overall low (alignment of sequences is shown in [6,13]) The phosphorylations have been charac-terized in ovine (Ovis aries), caprine (Capra hircus), bovine (Bos taurus), water buffalo (Bubalus bubalis) and camel (Camelus dromedarius) as1-casein Generally, all of these species have been reported to have a significant higher number of phosphorylations than shown to be the case for human as1-casein in this study Bovine as1-casein is phos-phorylated at up to nine positions depending on the genetic variants [3], the ovine as1-casein is phosphorylated at up to
11 positions [5], the water buffalo as1-casein is phospho-rylated at 6–8 positions [6], the caprine counterpart is phosphorylated at 9–10 positions [4], and camel as1-casein is phosphorylated at up to six serines [7] The most striking difference in the phosphorylation pattern between human
as1-casein and its ruminant counterparts is the shortage of phosphorylation in the serine-rich region consisting of residues Ser70–Glu78 in the human sequence This region has been shown to be highly phosphorylated in all the above mentioned species In this study, we have isolated the tryptic peptide covering residues Met68–Lys83, which contains the serine-rich region, in a nonphosphorylated form, and no traces of a phosphorylated form of this peptide were observed
The lack of phosphorylation at other positions reported
to be modified in ovine, caprine and bovine as1-casein (serines 41, 46, 48, 75 and 115 in all species, and Ser12 in ovine as1-casein, all numbers referring to the ruminant sequences), can simply be explained by sequence substitu-tions at these posisubstitu-tions, leaving no hydroxyamino acids to
be phosphorylated at these positions in human as1-casein The region containing the phosphorylated residues, Ser18
Fig 4 MALDI-TOF MS of intact human a s1 -casein The peak at m/z
20233 corresponds well to the calculated mass of human a s1 -casein including two phosphate groups (20246 Da) The peak at m/z 10121 represents the doubly protonated species (M2H+).
Trang 5and Ser26, in human as1-casein is not especially well
conserved among the other analyzed species The sequence
containing Ser18 in the human as1-casein is part of exon
3 in the human as1-casein gene, which is not present in the
ruminant species [13] Ser26, situated in exon 5 of the human
as1-casein gene, is not conserved in any other species except
the wallaby, in which the phosphorylation pattern has not
been determined [19]
During the review of these results, we were puzzled by the
lack of phosphorylation in the conserved region Ser70–
Glu78, which is so extensively phosphorylated in the
ruminant species To test whether our results were
repre-sentative, milk from three different women was analyzed
as1-Casein was purified and the reversed-phase traces of
tryptic digests of the protein were compared and found to be
identical in all cases, thereby showing similar
phosphoryla-tion of the protein in different individuals The
phosphory-lation pattern of human as1-casein described here, and
especially the lack of phosphorylations in the region Ser70–
Glu78, is therefore unlikely to be a result of intra-species
post-translational polymorphism in the protein However, it
should be emphasized that it is more difficult to show the
absence of a modification convincingly than its presence;
hence the existence of minor species partially
phosphory-lated at the region discussed can not be entirely excluded
The deletion of 11 amino acids at positions 59–69 and of
37 amino acids at positions 59–95 in caprine as1-casein leads
to the variants D and F In both cases these deletions, which
start at the same position of the polypeptide chain, include
the major phosphorylation site of the protein [20] In
ruminant milk, as1-casein, as well as the other three caseins
as2-, b- and j-casein is present in micellar structures
responsible for the calcium transport to the neonates
Compared with ruminant milk, the milk of primates holds a
much lower concentration of calcium and a function of as1
-casein in calcium transport in human milk is not likely
Recent studies of caprine as1-casein suggest that the protein
interacts with the other caseins in the rough endoplasmic
reticulum and that the formation of this complex is required
for their efficient export to the Golgi apparatus [21]
Whether a similar scenario exists in the human system
remains to be elucidated
Acknowledgments
Special thanks to H Breinholt and K.-E Højbjerg, Department of
Obstetrics and Gynaecology, University Hospital of Aarhus, for
providing the individual milk samples.
References
1 Jennes, R & Holt, C (1987) Casein and lactose in milk of 31
species are negatively correlated Experentia 43, 1015–1018.
2 Kunz, C & Lo¨nnerdal, B (1990) Casein and casein subunits in
preterm milk, colostrum, and mature human milk J Pediatr.
Gastroenterol Nutr 10, 454–461.
3 Mercier, J.C., Grosclaude, F & Ribadeau-Dumas, B (1971)
Structure primaire de la case´ine a s1 -bovine Eur J Biochem 23,
41–51.
4 Ferranti, P., Addeo, F., Malorni, A., Chianese, L., Leroux, C &
Martin, P (1997) Differential splicing of pre-messenger RNA
produces multiple forms of mature caprine a s1 -casein Eur J Biochem 249, 1–7.
5 Ferranti, P., Malorni, A., Nitti, G., Laezza, P., Pizzano, R., Chi-anese, L & Addeo, F (1995) Primary structure of ovine a s1 -caseins: localization of phosphorylation sites and characterization
of genetic variants A, C and D* J Dairy Res 62, 281–296.
6 Ferranti, P., Scaloni, A., Caira, S., Chianese, L., Malorni, A & Addeo, F (1998) The primary structure of water buffalo a s1 - and b-casein: characterization of a novel b-variant J Protein Chem.
17, 835–844.
7 Kappeler, S., Farah, Z & Puhan, Z (1998) Sequence analysis of Camelus dromedarius milk caseins J Dairy Res 65, 209–222.
8 Mercier, J.C (1981) Phosphorylation of caseins, present evidence for an amino acid triplet code posttranslationally recognized by specific kinases Biochimie (Paris) 63, 1–17.
9 Lasa-Benito, M., Marin, O., Meggio, F & Pinna, L.A (1996) Golgi apparatus mammary gland casein kinase: monitoring by a specific peptide substrate and definition of specificity determi-nants FEBS Lett 382, 149–152.
10 Greenberg, R., Groves, M.L & Dower, H.J (1984) Human beta-casein: amino acid sequence and identification of phosphorylation sites J Biol Chem 259, 5132–5138.
11 Cavaletto, M., Cantisani, A., Gluffrida, G., Napolitano, L & Conti, A (1994) Human a s1 -casein like protein: purification and N-terminal sequence determination Biol Chem Hoppe-Seyler
375, 149–151.
12 Rasmussen, L.K., Due, H.A & Petersen, T.E (1995) Human a s1 -casein: purification and characterization Comp Biochem Physiol 111B, 75–81.
13 Johnsen, L.B., Rasmussen, L.K., Petersen, T.E & Berglund, L (1995) Characterization of three types of human a s1 -casein mRNA transcripts Biochem J 309, 237–242.
14 Martin, P., Brignon, G., Furet, J.P & Leroux, C (1996) The gene encoding a s1 -casein is expressed in human mammary epithelial cells during lactation Lait 76, 523–535.
15 Meyer, H.E., Hoffmann-Posorske, E., Korte, H & Heilmyer, M.G Jr (1986) Sequence analysis of phosphoserine-containing peptides: modification for picomolar sensitivity FEBS Lett 204, 61–66.
16 Sørensen, E.S., Højrup, P & Petersen, T.E (1995) Posttransla-tional modifications of bovine osteopontin: identification of twenty-eight phosphorylation and three O-glycosylation sites Protein Sci 4, 2040–2049.
17 Sørensen, E.S & Petersen, T.E (1994) Identifi cation of two phosphorylation motifs in bovine osteopontin Biochem Biophys Res Commun 198, 200–205.
18 Rasmussen, L.K., Sørensen, E.S., Petersen, T.E., Nielsen, N.C & Thomsen, J.K (1997) Characterization of phosphate sites in native ovine, caprine and bovine casein micelles and their case-inomacropeptides: a solid-state31P NMR and sequence and mass spectrometric study J Dairy Sci 80, 607–614.
19 Ginger, M.R., Piotte, C.P., Otter, D.E & Grigor, M.R (1999) Identification, characterisation and cDNA cloning of two caseins from the common brushtail possum (Trichosurus vulpecula) 1 Biochim Biophys Acta 1427, 92–104.
20 Brignon, G., Mahe, M.F., Ribadeau-Dumas, B., Mercier J.C & Grosclaude, F (1990) Two of the three genetic variants of goat alpha s1-casein which are synthesized at a reduced level have an internal deletion possibly due to altered RNA splicing Eur J Biochem 193, 237–241.
21 Chanat, E., Martin, P & Ollivier-Bousquet, M (1999) a s1 -casein is required for the efficient transport of b- and j-casein from the endoplasmic reticulum to the Golgi apparatus of the mammary epithelial cells J Cell Sci 112, 3399–3412.